A Seattle-based company announced it has secured $8 million in seed funding to promote an artificial intelligence-powered platform to assist in mental health assessments.
Mental health screening company Aiberry’s funding effort was led by Confluence Capital Group, with participation from the venture capital fund Ascension AI.
With the seed funding secured, $10 million is expected to be funneled toward adoption of the company’s platform, an AI-powered therapeutic assistant that analyzes components of a conversation — including word choice, speech patterns and changes in facial expressions — between it and a patient to detect the possibility of mental health disorders. Read more.
